Sep 10, 2019 / 03:10PM GMT
David Reed Risinger - Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
So thanks, everyone, for joining us for the AbbVie session. I first need to refer you to disclaimers at www.morganstanley.com/researchdisclosures. It is very much my pleasure to welcome Rick Gonzalez, who's Chairman and CEO; and also Rob Michael, who's the company's CFO, onstage today. Unfortunately, Mike Severino was originally on the schedule but he had a family health issue so he wasn't able to join today, but we're happy that you can be here. And I thought it would be great to just have you, Rick, kick it off with some opening remarks and then we'll go from there.
Richard A. Gonzalez - AbbVie Inc. - Chairman & CEO
Certainly, David. Thank you for having us. It's an exciting time, obviously, for AbbVie. We're in the midst of a major acquisition that we plan on consummating in the first quarter. And I think that strategy will continue to advance the
Abbvie Inc at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers